Statistics from Altmetric.com
The work carried out by the authors on calcium and the cardiovascular risk is of primary importance.1 We thank the authors for questions and comments on the Strontium ranelate Efficacy in Knee OsteoarthrItis trIAl (SEKOIA) study, safety being a primary concern for us.2
The number of emergent adverse events reported in the SEKOIA study was similar in the three treatment groups: 85.8%, 87.9% and 86.5% in the SrRan 1g, SrRan 2g and placebo groups, as well as the number of serious emergent adverse events: 17.0%, 16.5% and 17.4%, respectively. The adverse reactions …
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.